Importantly, as described above, MALAT1, H19, TUG1, and ANRIL are also implicated in pulmonary vascular remodeling and PAH, however, whether the role they play in metabolic dysfunction in the disease is yet to be explored. Here, CDKN2B-AS1 is linked to pulmonary arterial hypertension.